Tetrazolones as inhibitors of fatty acid synthase
US9346769B2 · kind B2 · utility
2Cited by
63References
57Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 23, 2013 |
| Grant date | May 24, 2016 |
| Priority date | — |
| Expiry date | Aug 23, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are tetrazolone FASN inhibitors of the formula (I):or a pharmaceutically acceptable form thereof; wherein the variables RA, RB and RC are defined herein.Also provided herein are pharmaceutical compositions of the compounds provided herein as well as methods of their use for the treatment of various disorders such as hyperproliferative disorders, inflammatory disorders, obesity-related disorders and microbial infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.